TALZENNA
TALZENNA
Approved
DIN Number
02555050
Drug Class
Human
Market Date
May 16, 2025
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02555050
AIG Number0161811003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01XK04 TALAZOPARIB
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
TALAZOPARIB (TALAZOPARIB TOSYLATE)Active
Strength: 0.1 MG
Monograph: TALAZOPARIB (TALAZOPARIB TOSYLATE)